News

Pixantrone will be supplied by IDIS to healthcare professionals for the treatment of individual patients with relapsing aggressive non-Hodgkin’s lymphoma. This program is expected to be initiated by

The agreement comes after a successful implementation where GlaxoSmithKline (GSK) experienced the ease of use that empowers operators, engineers and management to positively affect their overall equipment effectiveness

The trial is being carried out in 30 hormone refractory prostate cancer patients with bone metastases in clinical centers in the US and several European countries. This study

The company will open a Phase I study evaluating safety of the Survivin antagonist during the first quarter of 2009. Survivin is a key protein that controls cancer

The FDA has asked for additional information regarding the company’s supplemental new drug application (sNDA) for Risperdal Consta long-acting injection. The sNDA, submitted in April 2008, sought approval

Mr Holmer previously served for two years on Inspire’s board, resigning in February 2007 to accept an appointment in the US Treasury Department. Mr Holmer has received an

The Mexican Government plans to install six Apollo Systems for the Mexico City Government Health Services, four Digital Apollo Systems for the ISSSTE (Government Workers Health and Social

Somatostatine-UCB is indicated for the treatment of acute upper gastrointestinal bleeding resulting from gastric and duodenal ulcers and other. UCB receives a cash consideration of an industry average

As one of the first companies to file an abbreviated new drug application containing a paragraph IV certification for this product, Teva has obtained a 180-day period of